CIBC Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

CIBC Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-55,296	Closed	-$10.2M	–	1512
2021 Q2	$10.2M	Sell	55,296 -82,298	-60%	-$14.1M	0.04%	233
2021 Q1	$21M	Sell	137,594 -9,384	-6%	-$1.45M	0.09%	137
2020 Q4	$23M	Buy	146,978 +991	+0.7%	+$127K	0.11%	129
2020 Q3	$16.7M	Buy	145,987 +31,969	+28%	+$3.45M	0.09%	139
2020 Q2	$12.8M	Buy	114,018 +388	+0.3%	+$41.2K	0.08%	147
2020 Q1	$10.2M	Buy	113,630 +25,938	+30%	+$2.55M	0.07%	159
2019 Q4	$9.48M	Buy	87,692 +16,136	+23%	+$1.73M	0.05%	159
2019 Q3	$7.01M	Buy	71,556 +10,854	+18%	+$1.22M	0.04%	193
2019 Q2	$7.95M	Buy	60,702 +7,484	+14%	+$965K	0.05%	169
2019 Q1	$7.19M	Sell	53,218 -4,246	-7%	-$528K	0.04%	186
2018 Q4	$5.59M	Buy	57,464 +1,933	+3%	+$228K	0.04%	184
2018 Q3	$7.72M	Buy	55,531 +528	+1%	+$66.2K	0.05%	164
2018 Q2	$6.83M	Buy	55,003 +1,091	+2%	+$128K	0.04%	174
2018 Q1	$6.01M	Buy	53,912 +17,979	+50%	+$2.15M	0.04%	188
2017 Q4	$4.3M	Buy	35,933 +8,156	+29%	+$993K	0.03%	249
2017 Q3	$3.9M	Buy	27,777 +257	+0.9%	+$34.9K	0.02%	261
2017 Q2	$3.35M	Buy	27,520 +783	+3%	+$91.1K	0.02%	281
2017 Q1	$3.24M	Buy	26,737 +676	+3%	+$87.2K	0.02%	290
2016 Q4	$3.19M	Buy	26,061 +353	+1%	+$43.2K	0.02%	286
2016 Q3	$3.15M	Sell	25,708 -1,815	-7%	-$234K	0.02%	291
2016 Q2	$3.21M	Buy	27,523 +205	+0.8%	+$29.1K	0.02%	280
2016 Q1	$3.8M	Buy	27,318 +496	+2%	+$72.8K	0.03%	233
2015 Q4	$5.12M	Sell	26,822 -678	-2%	-$118K	0.04%	179
2015 Q3	$4.3M	Buy	27,500 +2,013	+8%	+$367K	0.03%	200
2015 Q2	$4.61M	Buy	25,487 +2,262	+10%	+$390K	0.03%	220
2015 Q1	$4.03M	Buy	23,225 +1,887	+9%	+$342K	0.03%	229
2014 Q4	$3.95M	Sell	21,338 -5,386	-20%	-$998K	0.03%	226
2014 Q3	$4.43M	Sell	26,724 -30,073	-53%	-$4.94M	0.03%	230
2014 Q2	$8.88M	Buy	56,797 +5,055	+10%	+$798K	0.05%	149
2014 Q1	$7.87M	Buy	51,742 +588	+1%	+$93.5K	0.05%	161
2013 Q4	$6.8M	Sell	51,154 -2,613	-5%	-$314K	0.04%	178
2013 Q3	$6.25M	Sell	53,767 -10,887	-17%	-$1.19M	0.04%	179
2013 Q2	$5.96M	Buy	+64,654	New	+$6.23M	0.04%	175

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return